孤立性肺结节大小对18F-FDG PET/CT定性与定量评估的影响:SPUTNIK试验
SPUTNIK多中心前瞻性试验纳入CT上8–30 mm的孤立性肺结节患者355例,比较定性与半定量PET/CT标准的诊断效能,并分析结节大小的影响。结果显示SUVmax、SURBLOOD与SURLIVER的AUC均为0.87,各技术在不同大小三分位间AUC稳定,但最佳诊断阈值随结节大小变化。
要点
- SUVmax是诊断孤立性肺结节最准确的技术,AUC为0.87。
- SUVmax、SURBLOOD与SURLIVER三种半定量指标诊断效能无显著差异。
- 最佳诊断阈值随结节大小改变,<12 mm与>16 mm采用不同阈值。
核心结论
- 在本多中心试验中,SUVmax是诊断孤立性肺结节最准确的技术。
- 诊断阈值应根据结节大小进行调整。
研究设计与样本
- SPUTNIK试验为前瞻性多中心研究,在英国PET核心实验室认证的16个中心招募CT上≥8且≤30 mm的孤立性肺结节患者。
- 定性评估采用与纵隔血池比较的五分法PET分级,以及结合CT特征的PET/CT联合分级;半定量指标包括结节SUVmax、与纵隔血池的摄取比(SURBLOOD)和与肝脏的摄取比(SURLIVER)。
- 终点为经活检/组织学诊断肺癌或完成2年随访,共355例完成PET/CT与2年随访。
主要发现
- 355例完成PET/CT与2年随访的参与者中,恶性结节占59%(209/355)。
- SUVmax的AUC为0.87(95%CI 0.83;0.91),SURBLOOD的AUC为0.87(95%CI 0.83;0.91,与SUVmax比较p=0.30),SURLIVER的AUC为0.87(95%CI 0.83;0.91,与SUVmax比较p=0.09)。
- 所有技术的AUC在结节大小三分位间保持稳定(差异p>0.1),但最佳诊断阈值随大小变化。
- 对于<12 mm的结节,SUVmax 1.75或视觉摄取等于纵隔血池获得最高准确率。
- 对于>16 mm的结节,SUVmax≥3.6或视觉PET摄取大于纵隔血池最为准确。
关键数值与推荐
- 结节<12 mm:SUVmax 1.75或视觉摄取等于纵隔血池为最准确阈值。
- 结节>16 mm:SUVmax≥3.6或视觉PET摄取大于纵隔血池为最准确阈值。
- SUVmax、SURBLOOD、SURLIVER的AUC均为0.87(95%CI 0.83;0.91)。
临床怎么用
- 对孤立性肺结节行18F-FDG PET/CT时,可以SUVmax作为主要半定量指标。
- 判读时应根据结节大小选择相应诊断阈值,而非统一阈值。
- 对<12 mm结节可参考SUVmax 1.75或视觉摄取等于纵隔血池;对>16 mm结节可参考SUVmax≥3.6或视觉摄取大于纵隔血池。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare qualitative and semi-quantitative PET/CT criteria, and the impact of nodule size on the diagnosis of solitary pulmonary nodules in a prospective multicentre trial. METHODS: Patients with an SPN on CT ≥ 8 and ≤ 30 mm were recruited to the SPUTNIK trial at 16 sites accredited by the UK PET Core Lab. Qualitative assessment used a five-point ordinal PET-grade compared to the mediastinal blood pool, and a combined PET/CT grade using the CT features. Semi-quantitative measures included SUVmax of the nodule, and as an uptake ratio to the mediastinal blood pool (SURBLOOD) or liver (SURLIVER). The endpoints were diagnosis of lung cancer via biopsy/histology or completion of 2-year follow-up. Impact of nodule size was analysed by comparison between nodule size tertiles. RESULTS: Three hundred fifty-five participants completed PET/CT and 2-year follow-up, with 59% (209/355) malignant nodules. The AUCs of the three techniques were SUVmax 0.87 (95% CI 0.83;0.91); SURBLOOD 0.87 (95% CI 0.83; 0.91, p = 0.30 versus SUVmax); and SURLIVER 0.87 (95% CI 0.83; 0.91, p = 0.09 vs. SUVmax). The AUCs for all techniques remained stable across size tertiles (p > 0.1 for difference), although the optimal diagnostic threshold varied by size. For nodules < 12 mm, an SUVmax of 1.75 or visual uptake equal to the mediastinum yielded the highest accuracy. For nodules > 16 mm, an SUVmax ≥ 3.6 or visual PET uptake greater than the mediastinum was the most accurate. CONCLUSION: In this multicentre trial, SUVmax was the most accurate technique for the diagnosis of solitary pulmonary nodules. Diagnostic thresholds should be altered according to nodule size. TRIAL REGISTRATION: ISRCTN - ISRCTN30784948. ClinicalTrials.gov - NCT02013063.
引用
- Weir-McCall JR, Harris S, Miles KA, et al. Impact of solitary pulmonary nodule size on qualitative and quantitative assessment using 18F-fluorodeoxyglucose PET/CT: the SPUTNIK trial. Eur J Nucl Med Mol Imaging. 2020. PMID: 33130961. doi:10.1007/s00259-020-05089-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。